June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Microglia regulate blood vessel tone and blood flow in the retina via Cx3cr1, purinergic, and glutamatergic mechanisms
Author Affiliations & Notes
  • Michael Alexander Dixon
    Anatomy and Physiology, University of Melbourne, Melbourne, Victoria, Australia
  • Samuel Alexander Mills
    Monash University, Clayton, Victoria, Australia
  • Bang Bui
    Optometry and Vision Sciences, University of Melbourne, Melbourne, Victoria, Australia
  • Vickie Wong
    Optometry and Vision Sciences, University of Melbourne, Melbourne, Victoria, Australia
  • Da Zhao
    Optometry and Vision Sciences, University of Melbourne, Melbourne, Victoria, Australia
  • Andrew Ian Jobling
    Anatomy and Physiology, University of Melbourne, Melbourne, Victoria, Australia
  • Erica L Fletcher
    Anatomy and Physiology, University of Melbourne, Melbourne, Victoria, Australia
  • Footnotes
    Commercial Relationships   Michael Dixon None; Samuel Mills None; Bang Bui None; Vickie Wong None; Da Zhao None; Andrew Jobling None; Erica Fletcher None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 2943. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michael Alexander Dixon, Samuel Alexander Mills, Bang Bui, Vickie Wong, Da Zhao, Andrew Ian Jobling, Erica L Fletcher; Microglia regulate blood vessel tone and blood flow in the retina via Cx3cr1, purinergic, and glutamatergic mechanisms. Invest. Ophthalmol. Vis. Sci. 2023;64(8):2943.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Tight regulation of blood supply is critical for maintaining retinal homeostasis, however, the underlying mechanisms are largely unknown. Here, we examined how microglia contribute to vasoregulation in the retina

Methods : Live cell imaging was used to assess dynamic control of vessel calibre by microglia in retinal explants from Cx3cr1-GCaMP3 mice which express a genetically encoded Ca2+ indicator in microglia. Pharmacological agents used included ATP, the P2 antagonist PPADS, the mGluR agonist trans-ACPD, and fractalkine, the sole ligand for Cx3cr1. In vivo assessment of vessel calibre and blood flow was performed in C57BL/6J mice, and Cx3cr1+/GFP and Cx3cr1GFP/GFP mice using optical coherence tomography angiography and fluorescein angiography. Microglia from C57BL/6 and Cx3cr1GFP/GFP mice were also assessed for expression of vasoregulatory genes using RNAseq.

Results : Frequent spontaneous Ca2+ transients were observed in microglia which regularly (>60%) led to constriction of neighbouring capillaries. The magnitude of constriction was significantly correlated with the change in intracellular Ca2+ (n=253 events from 9 animals). These responses were significantly enhanced by application of exogenous ATP (n=3, p<0.005). Application of fractalkine also induced vasoconstriction but in the absence of microglial Ca2+ (n=3-4, p<0.05). In vivo imaging revealed loss of Cx3cr1 led to dilation of retinal capillaries (n=4-6, p<0.05) and altered blood flow (n=9-12, p<0.05). RNAseq data showed a significant downregulation of angiotensin converting enzyme (Ace; -9.5 fold change, n=5-6, p=9.9E-13), suggesting Cx3cr1 may regulate vessel calibre via the renin angiotensin system (RAS). This was confirmed by using a RAS inhibitor, which prevented fractalkine-induced vasoconstriction in retinal explants (n=9, p<0.05).

Conclusions : We have shown that retinal microglia can regulate vessel calibre via a Ca2+-dependent pathway mediated by purinergic and glutamatergic signalling, and a Ca2+-independent pathway mediated by Cx3cr1 and the RAS. These findings suggest microglia could be important for controlling retinal blood flow and may contribute to a greater understanding of CNS diseases that involve dysregulated blood supply.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×